Levi Jacob, Raymond Alice, Pozniak Anton, Vernazza Pietro, Kohler Philipp, Hill Andrew
School of Public Health, Imperial College London, London, UK.
St Stephen's Centre, Chelsea and Westminster Hospital, London, UK.
BMJ Glob Health. 2016 Sep 15;1(2):e000010. doi: 10.1136/bmjgh-2015-000010. eCollection 2016.
In 2014, the Joint United Nations Programme on HIV and AIDS (UNAIDS) and partners set the '90-90-90 targets'; aiming to diagnose 90% of all HIV positive people, provide antiretroviral therapy (ART) for 90% of those diagnosed and achieve viral suppression for 90% of those treated, by 2020. This results in 81% of all HIV positive people on treatment and 73% of all HIV positive people achieving viral suppression. We aimed to analyse how effective national HIV treatment programmes are at meeting these targets, using HIV care continuums or cascades.
We searched for HIV treatment cascades for 196 countries in published papers, conference presentations, UNAIDS databases and national reports. Cascades were constructed using reliable, generalisable, recent data from national, cross-sectional and longitudinal study cohorts. Data were collected for four stages; total HIV positive people, diagnosed, on treatment and virally suppressed. The cascades were categorised as complete (four stages) or partial (3 stages), and analysed for 'break points' defined as a drop >10% in coverage between consecutive 90-90-90 targets.
69 country cascades were analysed (32 complete, 37 partial). Diagnosis (target one-90%) ranged from 87% (the Netherlands) to 11% (Yemen). Treatment coverage (target two-81% on ART) ranged from 71% (Switzerland) to 3% (Afghanistan). Viral suppression (target three-73% virally suppressed) was between 68% (Switzerland) and 7% (China).
No country analysed met the 90-90-90 targets. Diagnosis was the greatest break point globally, but the most frequent key break point for individual countries was providing ART to those diagnosed. Large disparities were identified between countries. Without commitment to standardised reporting methodologies, international comparisons are complex.
2014年,联合国艾滋病规划署(UNAIDS)及其合作伙伴设定了“90-90-90目标”;旨在到2020年,诊断出90%的艾滋病毒阳性者,为其中90%的已诊断者提供抗逆转录病毒疗法(ART),并使接受治疗的患者中90%实现病毒抑制。这意味着81%的艾滋病毒阳性者接受治疗,73%的艾滋病毒阳性者实现病毒抑制。我们旨在利用艾滋病毒治疗连续体或级联来分析各国艾滋病毒治疗项目在实现这些目标方面的效果如何。
我们在已发表的论文、会议报告、UNAIDS数据库和国家报告中搜索了196个国家的艾滋病毒治疗级联。级联是使用来自国家、横断面和纵向研究队列的可靠、可推广的最新数据构建的。收集了四个阶段的数据;艾滋病毒阳性者总数、已诊断者、接受治疗者和病毒被抑制者。级联被分类为完整(四个阶段)或部分(三个阶段),并分析“断点”,定义为连续90-90-90目标之间覆盖率下降超过10%。
分析了69个国家的级联(32个完整,37个部分)。诊断率(第一个目标-90%)从87%(荷兰)到11%(也门)不等。治疗覆盖率(第二个目标-81%接受ART治疗)从71%(瑞士)到3%(阿富汗)不等。病毒抑制率(第三个目标-73%病毒被抑制)在68%(瑞士)和7%(中国)之间。
分析的国家中没有一个达到90-90-90目标。诊断是全球最大的断点,但各国最常见的关键断点是为已诊断者提供ART治疗。各国之间存在巨大差异。如果不采用标准化报告方法,国际比较会很复杂。